{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:47:02Z","timestamp":1768265222880,"version":"3.49.0"},"reference-count":32,"publisher":"European Respiratory Society (ERS)","issue":"3","license":[{"start":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T00:00:00Z","timestamp":1620864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/8\/5\/ITRC\/7\/2018\/ECD-I"],"award-info":[{"award-number":["5\/8\/5\/ITRC\/7\/2018\/ECD-I"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2021,4,8]]},"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Near-patient access to appropriate tests is a major obstacle for the efficient diagnosis of tuberculosis (TB) and associated drug resistance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We recently developed the \u201cTB Concentration &amp; Transport\u201d kit for bio-safe, ambient-temperature transportation of dried sputum on<jats:italic>Trans<\/jats:italic>-Filter, and the \u201cTB DNA Extraction\u201d kit for DNA extraction from<jats:italic>Trans<\/jats:italic>-Filter for determining drug resistance by DNA sequencing. In the present study, we evaluated the compatibility of Kit-extracted DNA with Hain's line probe assays (LPAs), which are endorsed by National TB programmes for the detection of drug resistance in sputum collected from presumptive multidrug-resistant TB patients (<jats:italic>n<\/jats:italic>=207).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p><jats:italic>Trans<\/jats:italic>-Filter-extracted DNA was seamlessly integrated with the LPA protocol (Kit-LPA). The sensitivity of Kit-LPA for determining drug resistance was 83.3% for rifampicin (95% CI 52\u201398%), 77.7% for isoniazid (95% CI 52\u201394%), 85.7% for fluoroquinolones (95% CI 42\u2013100%) and 66.6% for aminoglycosides (95% CI 9\u201399%), with a specificity range of 93.7% (95% CI 87\u201397) to 99.1% (95% CI 95\u2013100) using phenotypic drug susceptibility testing (DST) as a reference standard. A high degree of concordance was noted between results obtained from Kit-LPA and LPA (99% to 100% (\u03ba value: 0.83\u20131.0)).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study demonstrates successful integration of our developed kits with LPA. The adoption of these kits across Designated Microscopy Centres in India can potentially overcome the existing challenge of transporting infectious sputum at controlled temperature to centralised testing laboratories and can provide rapid near-patient cost-effective \u201cUniversal DST\u201d services to TB subjects residing in remote areas.<\/jats:p><\/jats:sec>","DOI":"10.1183\/23120541.00137-2021","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T14:45:46Z","timestamp":1620917146000},"page":"00137-2021","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Compatibility of a novel filter paper-based bio-safe sputum transport kit with line probe assay for diagnosing drug-resistant tuberculosis: a single-site evaluation study"],"prefix":"10.1183","volume":"7","author":[{"given":"Divya","family":"Anthwal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritu","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manpreet","family":"Bhalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajoy Kumar","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid Umar","family":"Khayyam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vithal Prasad","family":"Myneedu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Sarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashawant","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nalini Kant","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manjula","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6052-1137","authenticated-orcid":false,"given":"Jaya","family":"Sivaswami Tyagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8276-4458","authenticated-orcid":false,"given":"Sagarika","family":"Haldar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2021,5,13]]},"reference":[{"key":"2024101711095397000_7.3.00137-2021.1","unstructured":"WHO . Global Tuberculosis Report. Geneva, World Health Organization, 2020."},{"key":"2024101711095397000_7.3.00137-2021.2","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijtb.2020.08.019","article-title":"TB control in India in the COVID era","volume":"68","author":"Behra","year":"2021","journal-title":"Ind J Tuberculosis"},{"key":"2024101711095397000_7.3.00137-2021.3","unstructured":"NTEP . India TB Report-National Tuberculosis Elimination Programme Annual Report. India, National Tuberculosis Elimination Programme, 2020."},{"key":"2024101711095397000_7.3.00137-2021.4","unstructured":"WHO . Rapid Diagnostics for Tuberculosis Detection: WHO Consolidated Guidelines on Tuberculosis. Geneva, World Health Organization, 2020."},{"key":"2024101711095397000_7.3.00137-2021.5","unstructured":"RNTCP . Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India. India, Revised National TB Control Program, 2017."},{"key":"2024101711095397000_7.3.00137-2021.6","doi-asserted-by":"crossref","first-page":"e0220967","DOI":"10.1371\/journal.pone.0220967","article-title":"Development and evaluation of novel bio-safe filter paper-based kits for sputum microscopy and transport to directly detect Mycobacterium tuberculosis and associated drug resistance","volume":"14","author":"Anthwal","year":"2019","journal-title":"PLoS ONE"},{"key":"2024101711095397000_7.3.00137-2021.7","unstructured":"RNTCP . Technical and Operational Guidelines of Tuberculosis Control in India. India, Revised National TB Control Program, 2016."},{"key":"2024101711095397000_7.3.00137-2021.8","unstructured":"Global Laboratory Initiative. Stop TB Partnership. Mycobacteriology Laboratory Manual. First Edition. 2014."},{"key":"2024101711095397000_7.3.00137-2021.9","unstructured":"Hain-Lifesciences . GenoType MTBDRplus VER 2.0: Molecular Genetic Assay for Identification of the M. tuberculosis complex and its Resistance to Rifampicin and Isoniazid from Clinical Specimens and Cultivated Samples. Nehren, Germany, Hain-Lifesciences, 2012."},{"key":"2024101711095397000_7.3.00137-2021.10","unstructured":"Hain-Lifesciences . GenoType MTBDRsl VER 2.0: Molecular Genetic Assay for Identification of the M. tuberculosis Complex and its Resistance to Fluoroquinolones and Aminoglycosides\/Cyclic Peptides from Sputum Specimens or Cultivated Samples. Nehren, Germany, Hain-Lifesciences, 2015."},{"key":"2024101711095397000_7.3.00137-2021.11","unstructured":"Cepheid . Xpert MTB\/RIF Manual. Sunnyvale, CA, Cepheid, 2012."},{"key":"2024101711095397000_7.3.00137-2021.12","unstructured":"WHO . Technical Manual for Drug Susceptibility Testing of Medicines Used in the Treatment of Tuberculosis. Geneva, World Health Organization, 2018."},{"key":"2024101711095397000_7.3.00137-2021.13","unstructured":"WHO . Technical Report on Critical Concentrations for Drug Susceptibility Testing of Medicines used in the Treatment of Drug-Resistant Tuberculosis. Geneva, World Health Organization, 2018."},{"key":"2024101711095397000_7.3.00137-2021.14","doi-asserted-by":"publisher","DOI":"10.3758\/BRM.41.4.1149"},{"key":"2024101711095397000_7.3.00137-2021.15","unstructured":"RNTCP . National Strategic Plan for Tuberculosis Elimination 2017\u20132025. India, Revised National TB Control Program, 2017."},{"key":"2024101711095397000_7.3.00137-2021.16","unstructured":"WHO . Technical Expert Group Meeting Report: Commercial Products for Preserving Clinical Specimens for the Diagnosis of Tuberculosis. Geneva, World Health Organization, 2017."},{"key":"2024101711095397000_7.3.00137-2021.17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033275"},{"key":"2024101711095397000_7.3.00137-2021.18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119628"},{"key":"2024101711095397000_7.3.00137-2021.19","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00083-06"},{"key":"2024101711095397000_7.3.00137-2021.20","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01599-17"},{"key":"2024101711095397000_7.3.00137-2021.21","doi-asserted-by":"crossref","first-page":"114995","DOI":"10.1016\/j.diagmicrobio.2020.114995","article-title":"Genotypic characterization of \u2018inferred\u2019 rifampin mutations in GenoType MTBDRplus assay and its association with phenotypic susceptibility testing of Mycobacterium tuberculosis","volume":"96","author":"Singhal","year":"2020","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2024101711095397000_7.3.00137-2021.22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-12-9"},{"key":"2024101711095397000_7.3.00137-2021.23","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/tmi.12701","article-title":"Field evaluation of a novel preservation medium to transport sputum specimens for molecular detection of Mycobacterium tuberculosis in a rural African setting","volume":"21","author":"Omar","year":"2016","journal-title":"Trop Med Int Health"},{"key":"2024101711095397000_7.3.00137-2021.24","doi-asserted-by":"crossref","first-page":"16587","DOI":"10.1038\/s41598-019-53086-5","article-title":"A comparative evaluation of the new genexpert MTB\/RIF ultra and other rapid diagnostic assays for detecting tuberculosis in pulmonary and extra pulmonary specimens","volume":"9","author":"Osei Sekyere","year":"2019","journal-title":"Sci Rep"},{"key":"2024101711095397000_7.3.00137-2021.25","doi-asserted-by":"crossref","first-page":"847","DOI":"10.5588\/ijtld.13.0021","article-title":"A molecular transport medium for collection, inactivation, transport, and detection of Mycobacterium tuberculosis","volume":"18","author":"Daum","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024101711095397000_7.3.00137-2021.26","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit811"},{"key":"2024101711095397000_7.3.00137-2021.27","doi-asserted-by":"crossref","unstructured":"Daum LT , Konstantynovska OS , Solodiankin OS , et al. Next-generation sequencing for characterizing drug resistance-conferring Mycobacterium tuberculosis genes from clinical isolates in the Ukraine. J Clin Microbiol 2018; 56: e00009-18. doi:10.1128\/JCM.00009-18","DOI":"10.1128\/JCM.00009-18"},{"key":"2024101711095397000_7.3.00137-2021.28","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.diagmicrobio.2018.10.018","article-title":"Characterization of novel Mycobacterium tuberculosis pncA gene mutations in clinical isolates from the Ukraine","volume":"93","author":"Daum","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2024101711095397000_7.3.00137-2021.29","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268813002409"},{"key":"2024101711095397000_7.3.00137-2021.30","doi-asserted-by":"crossref","first-page":"e0173508","DOI":"10.1371\/journal.pone.0173508","article-title":"Transcriptome analysis of mycobacteria in sputum samples of pulmonary tuberculosis patients","volume":"12","author":"Sharma","year":"2017","journal-title":"PLoS ONE"},{"key":"2024101711095397000_7.3.00137-2021.31","doi-asserted-by":"crossref","first-page":"e0139382","DOI":"10.1371\/journal.pone.0139382","article-title":"Performance of four transport and storage systems for molecular detection of multidrug-resistant tuberculosis","volume":"10","author":"Rabodoarivelo","year":"2015","journal-title":"PLoS ONE"},{"key":"2024101711095397000_7.3.00137-2021.32","doi-asserted-by":"crossref","first-page":"741","DOI":"10.5588\/ijtld.17.0816","article-title":"Commercial products to preserve specimens for tuberculosis diagnosis: a systematic review","volume":"22","author":"Reeve","year":"2018","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00137-2021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:08:54Z","timestamp":1740373734000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00137-2021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,13]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,8,2]]},"published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1183\/23120541.00137-2021"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00137-2021","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,13]]}}}